To acquire Japanese pharma company for ~₹1,300 Crores
Gujarat Themis Biosyn Ltd · GUJTHEM · BSE ·
The company has signed an agreement to acquire 100% of MicroBiopharm Japan Co., Ltd. (MBJ), a Japanese pharmaceutical firm. The total deal value is approximately **₹1,300 Crores** (JPY 21.5 Billion). This is a strategic move to transform GTBL into a technology-driven Contract Dev…